Andrew, you make a very valid point when you say.. "Seems to me either it doesn't work, in which case it is worthless, or it is multiples of current level."
Yes, this is an all-or-nothing gamble. Either the product works (instant millionaires), or it doesn't (severe financial pain for some). Those who accept that notion accept the risk and go into this investment with open eyes, as they should.
Although Unknown has a rather extreme way of expressing it, his comments provide some balance to the endless stream of over-zealous faith that is constantly being expressed by some posters from the other side. His views, however, are no more "unsubstantiated" than those who continue to insist that great things are 'just around the corner' and that this stock is 'grossly undervalued'. The fact is, the company has not produced any evidence to suggest that such claims are valid.
There have been a number of trials and opportunities for the company to show real progress in this regard - where are the results (ferrets, anyone)?
As I have said before, this company has NEVER released a statement showing a negative, or adverse, outcome - the slightest indication of positive news, no matter how tenuous, however, arrives with much fanfare.
So, are there no results because:
a) they haven't been completed on schedule (if not, why not), or,
b) the results were unsatisfactory and the company chose not to release them
Every investor has to make that judgement for themselves. Based on MY experience with this company, I have formed the view that RCE does not yet have a marketable product, and maybe, never will have.
That is my unsubstantiated OPINION, so the easily offended can save their vitriol - I care naught for blind faith.
- Forums
- ASX - By Stock
- RCE
- RCE Charts
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.33%
!
31.0¢

RCE Charts, page-720
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 18938 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 0.300 |
2 | 34803 | 0.295 |
2 | 50000 | 0.290 |
4 | 131061 | 0.285 |
10 | 251389 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 18938 | 1 |
0.320 | 5000 | 1 |
0.325 | 12600 | 1 |
0.330 | 114230 | 1 |
0.350 | 51319 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online